To validate the clinical significance of MCM2 and MCM10, immunohistochemistry, evaluated by H-score, was used in a pilot study of 50 UTUC and 50 UBUC samples. This evidence concerns the gene MCM10 and renal pelvis/ureter urothelial carcinoma.